Back to Browse Journals » Integrated Blood Pressure Control » Volume 4

A critical appraisal of the clinical effectiveness of a fixed combination of valsartan, amlodipine, and hydrochlorothiazide in achieving blood pressure goals

Authors Cheryl L Laffer, Fernando Elijovich

Published 19 January 2011 Volume 2011:4 Pages 1—5


Review by Single-blind

Peer reviewer comments 3

Cheryl L Laffer1, Fernando Elijovich2
1Section of Hypertension and Vascular Medicine, 2Division of General Internal Medicine, Department of Medicine, Texas A&M Health Sciences Center College of Medicine, Temple, TX USA

Abstract: Recent guidelines for the treatment of hypertension have focused on the need for multiple medications to get most patients to goal blood pressure (BP). Two to three different classes of antihypertensive agents are frequently required, increasing the risk of poor compliance with therapy. Hence, the guidelines have recommended starting with combination therapy in patients with BP that is over 20 mm Hg systolic or 10 mm Hg diastolic above goal. The latest advance in treatment regimen has been the development of triple-therapy combinations of an angiotensin receptor blocker, amlodipine, and hydrochlorothiazide. We review the pathophysiologic rationale for such a combination and the efficacy, safety, and tolerability of the first triple therapy that has become available: valsartan + amlodipine + hydrochlorothiazide. Finally, we suggest that use of triple therapy could improve the accuracy of diagnosing resistant hypertension, an increasingly prevalent and severe condition, by enhancing adherence to treatment and weeding out patients with pseudoresistance. This would allow for implementation of expensive and invasive workup only in those truly resistant patients in whom it is justified.

Keywords: combination therapy, compliance, hypertension control rates, resistant hypertension

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] View Full Text [HTML] 


Readers of this article also read:

Efficacy and safety of cross-linked hyaluronic acid single injection on osteoarthritis of the knee: a post-marketing phase IV study

Bashaireh K, Naser Z, Hawadya KA, Sorour S, Al-Khateeb RN

Drug Design, Development and Therapy 2015, 9:2063-2072

Published Date: 8 April 2015

Antithrombotic therapy in elderly patients with non-valvular atrial fibrillation: a pilot study

Xiang W, Zhang JW, Liu ML, Liu F, Feng XR, Wang YC

Clinical Interventions in Aging 2015, 10:515-519

Published Date: 2 March 2015

Altered diastolic function and aortic stiffness in Alzheimer’s disease

Çalık AN, Özcan KS, Yüksel G, Güngör B, Aruğarslan E, Varlibas F, Ekmekci A, Osmonov D, Tatlısu MA, Karaca M, Bolca O, Erdinler I

Clinical Interventions in Aging 2014, 9:1115-1121

Published Date: 16 July 2014

Association of treatment and outcomes of doctor-shopping behavior in patients with hepatocellular carcinoma

Hsieh CI, Chung KP, Yang MC, Li TC

Patient Preference and Adherence 2013, 7:693-701

Published Date: 11 July 2013

Current perspectives on rosuvastatin

Hu M, Tomlinson B

Integrated Blood Pressure Control 2013, 6:15-25

Published Date: 18 April 2013

Effects of vildagliptin (Galvus®) therapy in patients with type 2 diabetes mellitus after heart transplantation

Gueler I, Mueller S, Helmschrott M, Oeing CU, Erbel C, Frankenstein L, Gleissner C, Ruhparwar A, Ehlermann P, Dengler TJ, Katus HA, Doesch AO

Drug Design, Development and Therapy 2013, 7:297-303

Published Date: 8 April 2013

Supplementing five-point body condition score with body fat percentage increases the sensitivity for assessing overweight status of small to medium sized dogs

Li GB, Lee P, Mori N, Yamamoto I, Kawasumi K, Tanabe H, Arai T

Veterinary Medicine: Research and Reports 2012, 3:71-78

Published Date: 5 September 2012

Objective and subjective in vivo comparison of two emollient products

Djokic-Gallagher J, Rosher P, Walker J, Hart V

Clinical, Cosmetic and Investigational Dermatology 2012, 5:85-91

Published Date: 8 August 2012

Synergetic effects of doxycycline-loaded chitosan nanoparticles for improving drug delivery and efficacy

Cover NF, Lai-Yuen S, Parsons AK, Kumar A

International Journal of Nanomedicine 2012, 7:2411-2419

Published Date: 25 June 2012